Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
ID | DOID:3846 |
Name | adamantinous craniopharyngioma |
Definition | |
Source | DiseaseOntology.org |
Alt Ids | |
Path | disease disease of cellular proliferation benign neoplasm organ system benign neoplasm nervous system benign neoplasm central nervous system benign neoplasm craniopharyngioma adamantinous craniopharyngioma |
Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03970226 | Phase I | Tocilizumab | Tocilizumab in Children With ACP | Recruiting | USA | 0 |
NCT05233397 | Phase II | Tocilizumab | ACTEMRA for the Treatment of Pediatric Adamantinomatous Craniopharyngioma | Recruiting | USA | CAN | AUS | 0 |
NCT05286788 | Phase II | Binimetinib | MEKTOVI for the Treatment of Pediatric Adamantinomatous Craniopharyngioma | Recruiting | USA | CAN | AUS | 0 |